Sung Joseph J Y, Chiu Han-Mo, Lieberman David, Kuipers Ernst J, Rutter Matthew D, Macrae Finlay, Yeoh Khay-Guan, Ang Tiing Leong, Chong Vui Heng, John Sneha, Li Jingnan, Wu Kaichun, Ng Simon S M, Makharia Govind K, Abdullah Murdani, Kobayashi Nozomu, Sekiguchi Masau, Byeon Jeong-Sik, Kim Hyun-Soo, Parry Susan, Cabral-Prodigalidad Patricia Anne I, Wu Deng-Chyang, Khomvilai Suparkij, Lui Rashid N, Wong Sunny, Lin Yu-Min, Dekker E
Lee Kong Chian School of Medicine, Singapore
Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Gut. 2022 Nov;71(11):2152-2166. doi: 10.1136/gutjnl-2022-327377. Epub 2022 Aug 24.
The Asia-Pacific region has the largest number of cases of colorectal cancer (CRC) and one of the highest levels of mortality due to this condition in the world. Since the publishing of two consensus recommendations in 2008 and 2015, significant advancements have been made in our knowledge of epidemiology, pathology and the natural history of the adenoma-carcinoma progression. Based on the most updated epidemiological and clinical studies in this region, considering literature from international studies, and adopting the modified Delphi process, the Asia-Pacific Working Group on Colorectal Cancer Screening has updated and revised their recommendations on (1) screening methods and preferred strategies; (2) age for starting and terminating screening for CRC; (3) screening for individuals with a family history of CRC or advanced adenoma; (4) surveillance for those with adenomas; (5) screening and surveillance for sessile serrated lesions and (6) quality assurance of screening programmes. Thirteen countries/regions in the Asia-Pacific region were represented in this exercise. International advisors from North America and Europe were invited to participate.
亚太地区是全球结直肠癌(CRC)病例数最多、因该病导致死亡率最高的地区之一。自2008年和2015年发布两项共识建议以来,我们在腺瘤-癌进展的流行病学、病理学及自然史方面的认识取得了重大进展。基于该地区最新的流行病学和临床研究,参考国际研究文献,并采用改良德尔菲法,亚太地区结直肠癌筛查工作组更新并修订了其关于以下方面的建议:(1)筛查方法和首选策略;(2)CRC筛查开始和终止年龄;(3)有CRC或高级别腺瘤家族史者的筛查;(4)腺瘤患者的监测;(5)无蒂锯齿状病变的筛查和监测;(6)筛查项目的质量保证。本次活动有亚太地区13个国家/地区参与。还邀请了来自北美和欧洲的国际顾问参与。